Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

101 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Special considerations in the use of cardiovascular drugs.
Ueland K, McAnulty JH, Ueland FR, Metcalfe J. Ueland K, et al. Among authors: ueland fr. Clin Obstet Gynecol. 1981 Sep;24(3):809-23. doi: 10.1097/00003081-198109000-00008. Clin Obstet Gynecol. 1981. PMID: 7026105 Review. No abstract available.
Relating ovarian size to age, menopausal status, and use of hormones.
Pavlik EJ, Liu C, DePriest PD, Gallion HH, Ueland FR, Kryscio RJ, van Nagell JR Jr. Pavlik EJ, et al. Among authors: ueland fr. Gynecol Oncol. 2001 Feb;80(2):333-4. doi: 10.1006/gyno.2000.6114. Gynecol Oncol. 2001. PMID: 11161877 No abstract available.
Phase III Randomized Trial of Maintenance Taxanes Versus Surveillance in Women With Advanced Ovarian/Tubal/Peritoneal Cancer: A Gynecologic Oncology Group 0212:NRG Oncology Study.
Copeland LJ, Brady MF, Burger RA, Rodgers WH, Huang HQ, Cella D, O'Malley DM, Street DG, Tewari KS, Bender DP, Morris RT, Lowery WJ, Miller DS, Dewdney SB, Spirtos NM, Lele SB, Guntupalli S, Ueland FR, Glaser GE, Mannel RS, DiSaia PJ. Copeland LJ, et al. Among authors: ueland fr. J Clin Oncol. 2022 Dec 10;40(35):4119-4128. doi: 10.1200/JCO.22.00146. Epub 2022 Jun 27. J Clin Oncol. 2022. PMID: 35759733 Free PMC article. Clinical Trial.
Clinical activity of gemcitabine plus pertuzumab in platinum-resistant ovarian cancer, fallopian tube cancer, or primary peritoneal cancer.
Makhija S, Amler LC, Glenn D, Ueland FR, Gold MA, Dizon DS, Paton V, Lin CY, Januario T, Ng K, Strauss A, Kelsey S, Sliwkowski MX, Matulonis U. Makhija S, et al. Among authors: ueland fr. J Clin Oncol. 2010 Mar 1;28(7):1215-23. doi: 10.1200/JCO.2009.22.3354. Epub 2009 Nov 9. J Clin Oncol. 2010. PMID: 19901115 Clinical Trial.
101 results